Topics

Aurinia Pharmaceuticals' experimental drug for lupus nephritis, an autoimmune kidney disease, achieved allefficacy goals in a late-stage clinical trial. https://buff.ly/2qkB6Cn 

19:00 EST 4 Dec 2019 | STAT

Aurinia Pharmaceuticals' experimental drug for lupus nephritis, an autoimmune kidney disease, achieved allefficacy goals in a late-stage clinical trial. https://buff.ly/2qkB6Cn 

Original Article: Aurinia Pharmaceuticals' experimental drug for lupus nephritis, an autoimmune kidney disease, achieved allefficacy goals in a late-stage clinical trial. https://buff.ly/2qkB6Cn 

NEXT ARTICLE

More From BioPortfolio on "Aurinia Pharmaceuticals' experimental drug for lupus nephritis, an autoimmune kidney disease, achieved allefficacy goals in a late-stage clinical trial. https://buff.ly/2qkB6Cn "

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Lupus
Lupus is a complex and poorly understood condition that affects many parts of the body and causes symptoms ranging from mild to life-threatening. There are several types of lupus. The main types are: discoid lupus erythematosus drug-induced lu...